Hope for mitochondrial patients: new drug targets debilitating fatigue
Symptom relief
Recruiting now
This study tests whether the experimental drug sonlicromanol can reduce fatigue and improve physical abilities like balance and leg strength in adults with a specific genetic mitochondrial disease (m.3243A>G mutation). About 220 participants will receive either the drug or a plac…
Phase: PHASE3 • Sponsor: Khondrion BV • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC